Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition

Phase 3 Completed 60 enrolled Yuhan Corporation

RandomizedParallel-groupOpen-labelTreatment

Summary

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 versus NTCB-P in patients who require parenteral nutrition

Timeline

Start: 2024-11-14
Primary completion: 2025-03-28
Completion: 2025-03-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	NTCB-P	Unknown	—	—
Subject	NTCB01-1	Unknown	—	—

Indications

No indication recorded.